Pediatric Patients Undergoing Surgery with Peroperative SARS-Cov-2 Infection: An Iranian Case Brief Report Peroperative SARS-Cov-2 Infection in Pediatric Patients Undergoing Surgery
Iranian Journal of Pediatric Surgery,
Vol. 7 No. 2 (2021),
12 Khordad 2021
,
Page 121-125
https://doi.org/10.22037/irjps.v7i2.34959
Abstract
Introduction: The present study aimed to assess COVID-19 disease complications and its related 30-day mortality in pediatric patients with perioperative SARS-CoV-2 infection who had surgery.
Materials and Methods: A multi-center, prospective, brief report of pediatric patients who had surgery at 6 hospitals in 4 cities of Khuzestan Province, South-western Iran, one of the provinces with the highest prevalence and death rates due to COVID-19 disease. COVID-19 status and its effect on the course and outcome of the patients was investigated.
Results: 246 pediatric patients who had surgery between Jan 20 and Jun 01, 2020 with a 30-day follow-up period enrolled in the study. Four (1.62%) of the 246 patients who underwent surgery had perioperative COVID-19 infection. The most common symptoms included dyspnea, fever, and cough. Surgical procedures included total gastrectomy and esophagojejunostomy, bilateral pleural effusions tap, catheter placement for dialysis, and CV-line placement. Three patients had comorbidities including congestive heart failure (CHF), end-stage renal disease (ESRD), and diabetes.
Conclusion: Based on our results, it can be said that the prevalence of this disease in children is lower than the average of the society; and the outcome in younger patients seems to be better. Though it seems that COVID-19 disease is a low risk and somehow benign condition in children undergoing surgery, but due to the unpredictable nature of the disease, public health recommendations at both general and special levels have been made by the World Health Organization (WHO) to prevent the disease. Further studies with larger samples are necessary to confirm our findings and to clarify which age groups are at increased risk for developing severe COVID-19 infection and its related morbidities and death.
- COVID-19 infection
- 30-Day mortality
- Comorbidities
How to Cite
References
Lai C, Shih T, Ko W, et al: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020;55(3):105924-9.
Ludwig S, Zarbock A: Coronaviruses and SARS-CoV-2: A Brief Overview. Anesth Analg 2020;131(1):93-6.
Besnier E, Tuech J, Schwarz L: We Asked the Experts: Covid-19 Outbreak: Is There Still a Place for Scheduled Surgery? "Reflection from Pathophysiological Data". World J Surg 2020;44(6):1695-8.
Stephan M , Concato J , Kemper E , et al: an international cohort study. Lancet 2020;11:53-9.
Sadeghi A, Bagheri-Lankarani K: Iranian National guideline on Endoscopy during COVID-19 Pandemic. shiraz E-Med J 2020;25(1):7.
Karimi A, Rafiei Tabatabaei S, Rajabnejad M, et al: An Algorithmic Approach to Diagnosis and Treatment of Coronavirus Disease 2019 (COVID-19) in Children: Iranian Expert’s Consensus Statement. Arch Pediatr Infect Dis 2020;8(2):134-8.
- Abstract Viewed: 141 times
- PDF Downloaded: 151 times